pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Cardiology · news · pharmadog
← back to Cardiology
News · Cardiology
591
stories
18d
Longeveron’s phase 2b stem cell flop spurs cost cutting, exploration of ‘all options’
fiercebiotech
19d
New lawsuit argues NIH violated First Amendment rights of grant applicants
stat
19d
Convergence: Califf says regulations ‘need an update,’ sees AI assistants in regulatory future
raps
19d
Novartis halts TREM2 targeting ALS program in 4th trial stumble in a month
biospace
19d
U.S. reaches highest number of measles deaths in decades
stat
19d
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
biospace
19d
Novo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotech
fiercebiotech
19d
5 biotechs braving the commercial waters with product launches
biospace
20d
FDA clears first generic radioligand drug; Sionna turns to layoffs
biopharma dive
20d
WCLC ‘26: A new ‘ADC era,’ China questions and AstraZeneca’s spotlight
biopharma dive
20d
STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseases
stat
20d
Businesses can now apply for NIH funding
stat
20d
Exercise — and echocardiograms — in space protected astronauts’ hearts in study
stat
20d
Novo walks away from $285M pact to develop monthly GLP-1 obesity drug with Ascendis
fiercebiotech
21d
A&P Creations LLC Issues Nationwide Recall of biQ-FEL Due to Undeclared Sildenafil and Tadalafil
fda recalls
21d
A&P Creations LLC Issues Nationwide Recall of X10 Natural Enhancement Supplement Due to Undeclared Sildenafil and Tadalafil
fda recalls
21d
Cellectis quits CAR-T and pivots to ‘in vivo’ gene editing
biopharma dive
21d
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
biospace
21d
Psychedelic therapies ride wave of public favor into FDA hearing
biospace
24d
This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree
biopharma dive
24d
STAT+: Cancer drug shortages keep disrupting patient care
stat
24d
Boycott launched against American Diabetes Association includes journal
stat
24d
Novartis drags peers down with triple asset stumble
biospace
24d
Novartis drags peers down with triple asset failure
biospace
24d
STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field
stat
24d
STAT+: An AI tool aims to catch harder-to-detect heart attacks in EKGs
stat
24d
Novartis’ board faces investor scrutiny after M&A misfires and R&D flops
biospace
25d
Scientists boycott American Diabetes Association as fallout of June conference fracas escalates
fiercebiotech
25d
Platinum-based chemotherapy in childhood causes mutations that age the liver
stat
25d
Why two promising heart drugs flopped and what’s next
stat
← prev
page 4 of 20
next →
